Intellia Therapeutics (NTLA) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.52
-1.38
-1.24
-1.1

Details

Expected EPS
-1.27904
Actual EPS
-1.1
Surprise EPS
0.18
Surprise Percent
+14%

Description

Intellia Therapeutics (NTLA) has reported earnings of -1.1 per share for Q2 2025.

0 Comments

Share your thoughts